NeoGenomics, Inc. (NEO)
9.44
+0.18
(+1.94%)
USD |
NASDAQ |
May 01, 16:00
9.62
+0.18
(+1.91%)
After-Hours: 20:00
NeoGenomics Enterprise Value : 1.492B for May 1, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| UnitedHealth Group, Inc. | 414.07B |
| ADMA Biologics, Inc. | 2.498B |
| Amphastar Pharmaceuticals, Inc. | 1.363B |
| Krystal Biotech, Inc. | 7.013B |
| Monte Rosa Therapeutics, Inc. | 1.166B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.11M |
| Revenue (Quarterly) | 186.67M |
| Total Expenses (Quarterly) | 203.78M |
| EPS Diluted (Quarterly) | -0.1324 |
| Gross Profit Margin (Quarterly) | 41.70% |
| Profit Margin (Quarterly) | -9.16% |
| Earnings Yield | -8.19% |
| Normalized Earnings Yield | -6.172 |